» Authors » Aijia Wang

Aijia Wang

Explore the profile of Aijia Wang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 177
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sayer G, Ahmed M, Mehra M, Gosev I, Vidula H, DeVore A, et al.
J Card Fail . 2025 Jan; PMID: 39855458
Background: The benefit of implantable cardioverter-defibrillators (ICDs) and cardiovascular resynchronization therapy defibrillators (CRT-Ds) in patients supported with a HeartMate 3 left ventricular assist device (LVAD) remains uncertain. Methods: An analysis...
2.
Wang A, Chen Y, Zhang X, Liu M, Liu S, Kozyraki R, et al.
Dev Dyn . 2025 Jan; PMID: 39853824
Background: Endocytosis of enamel matrix proteins (EMPs) by ameloblasts is a key process in the mineralization of enamel during the maturation stage of amelogenesis. However, the relevant receptor mediating endocytosis...
3.
Molina E, Ahmed M, Sheikh F, Cleveland Jr J, Goldstein D, Uriel N, et al.
JACC Heart Fail . 2024 Dec; PMID: 39708027
Background: Prior analyses have suggested that a smaller left ventricular end-diastolic diameter (LVEDD) is associated with reduced survival following HeartMate 3 left ventricular assist device implantation. Objectives: In this trial-based...
4.
Wang A, Qin K, Ma S
Infect Drug Resist . 2024 Nov; 17:5061-5072. PMID: 39559343
Background: Using antimicrobials wisely is crucial for effective treatment and reducing antimicrobial resistance (AMR). As ocular infections can lead to serious consequences and ophthalmic surgery has a great impact on...
5.
Nagai M, Porter R, Miyasato M, Wang A, Gavilan C, Hughes E, et al.
J Biol Chem . 2024 Oct; 300(11):107881. PMID: 39395799
PHF21A is a histone-binding protein that recognizes unmethylated histone H3K4, the reaction product of LSD1 histone demethylase. PHF21A and LSD1 form a complex, and both undergo neuron-specific microexon splicing. The...
6.
Schmitto J, Shaw S, Garbade J, Gustafsson F, Morshuis M, Zimpfer D, et al.
Eur Heart J . 2023 Nov; 45(8):613-625. PMID: 38036414
Background And Aims: HeartMate 3 (HM3) is a fully magnetically levitated continuous flow left ventricular assist device, which received CE marking in 2015. The ELEVATE Registry was initiated to collect...
7.
Wang A, Zhang H, Li X, Zhao Y
Neural Regen Res . 2023 Sep; 19(3):591-597. PMID: 37721289
The therapeutic potential of Annexin A1, an important member of the Annexin superfamily, has become evident in results of experiments with multiple human systems and animal models. The anti-inflammatory and...
8.
Nayak A, Hall S, Uriel N, Goldstein D, Cleveland Jr J, Cowger J, et al.
J Am Coll Cardiol . 2023 Aug; 82(9):771-781. PMID: 37612008
Background: In advanced heart failure patients implanted with a fully magnetically levitated HeartMate 3 (HM3, Abbott) left ventricular assist device (LVAD), it is unknown how preimplant factors and postimplant index...
9.
Uriel N, Milano C, Agarwal R, Lee S, Cleveland J, Goldstein D, et al.
Eur J Heart Fail . 2022 Nov; 25(2):286-294. PMID: 36404406
Aims: We assessed the incidence, predictors and clinical correlates of de-novo aortic regurgitation (AR), which physiologically reduces left ventricular assist device (LVAD) effectiveness due to recirculation syndrome, in the MOMENTUM...
10.
Mehra M, Goldstein D, Cleveland J, Cowger J, Hall S, Salerno C, et al.
JAMA . 2022 Sep; 328(12):1233-1242. PMID: 36074476
Importance: Although durable left ventricular assist device (LVAD) therapy has emerged as an important treatment option for patients with advanced heart failure refractory to pharmacological support, outcomes, including survival, beyond...